Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
Racil Z, Razga F, Klamova H, Voglova J, Belohlavkova P, Malaskova L, Potesil D, Muzik J, Zackova D, Polakova KM, Zdrahal Z, Malakova J, Suttnar J, Dyr J, Mayer J. Racil Z, et al. Among authors: muzik j. Hematol Oncol. 2014 Jun;32(2):87-93. doi: 10.1002/hon.2091. Epub 2013 Aug 20. Hematol Oncol. 2014. PMID: 23963760
Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.
Holzerová M, Faber E, Veselovská J, Urbánková H, Balcárková J, Rozmanová S, Voglová J, Muzík J, Chroust K, Indrák K, Jarosová M; CAMELIA-Chronic Myeloid Leukaemia Project. Holzerová M, et al. Among authors: muzik j. Cancer Genet Cytogenet. 2009 May;191(1):1-9. doi: 10.1016/j.cancergencyto.2008.12.013. Cancer Genet Cytogenet. 2009. PMID: 19389502
Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?
Zackova D, Klamova H, Dusek L, Muzik J, Polakova KM, Moravcova J, Jurcek T, Dvorakova D, Racil Z, Pospisil Z, Oltova A, Michalova K, Brezinova J, Razga F, Doubek M, Cetkovsky P, Trneny M, Mayer J. Zackova D, et al. Among authors: muzik j. Am J Hematol. 2011 Mar;86(3):318-21. doi: 10.1002/ajh.21942. Epub 2011 Feb 15. Am J Hematol. 2011. PMID: 21328429 Free article. No abstract available.
Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
Faber E, Mužík J, Koza V, Demečková E, Voglová J, Demitrovičová L, Chudej J, Markuljak I, Cmunt E, Kozák T, Tóthová E, Jarošová M, Dušek L, Indrák K. Faber E, et al. Among authors: muzik j. Eur J Haematol. 2011 Aug;87(2):157-68. doi: 10.1111/j.1600-0609.2011.01637.x. Eur J Haematol. 2011. PMID: 21535160
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.
Pavlík T, Janoušová E, Pospíšil Z, Mužík J, Záčková D, Ráčil Z, Klamová H, Cetkovský P, Trněný M, Mayer J, Dušek L. Pavlík T, et al. Among authors: muzik j. BMC Med Res Methodol. 2011 Oct 11;11:140. doi: 10.1186/1471-2288-11-140. BMC Med Res Methodol. 2011. PMID: 21988861 Free PMC article.
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Racil Z, Weinbergerova B, Kocmanova I, Muzik J, Kouba M, Drgona L, Masarova L, Guman T, Tothova E, Forsterova K, Haber J, Ziakova B, Bojtarova E, Vydra J, Mudry P, Foralova R, Sejnova D, Mallatova N, Kandrnal V, Cetkovsky P, Mayer J. Racil Z, et al. Among authors: muzik j. Int J Infect Dis. 2013 Feb;17(2):e101-9. doi: 10.1016/j.ijid.2012.09.004. Epub 2012 Oct 22. Int J Infect Dis. 2013. PMID: 23084969 Free article.
Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.
Zackova D, Klamova H, Muzik J, Cmunt E, Racil Z, Machova Polakova K, Dvorakova D, Jurcek T, Razga F, Cetkovsky P, Dusek L, Mayer J. Zackova D, et al. Among authors: muzik j. Leuk Lymphoma. 2013 Oct;54(10):2310-3. doi: 10.3109/10428194.2013.772173. Epub 2013 Feb 28. Leuk Lymphoma. 2013. PMID: 23373966 No abstract available.
131 results